Warfarin Versus Aspirin for Prevention of Cognitive Decline in Atrial Fibrillation: Randomized Controlled Trial (Birmingham Atrial Fibrillation Treatment of the Aged Study) [Clinical Sciences]
Conclusions—
We found no evidence that anticoagulation confers clinically important protection over aspirin against cognitive decline as measured by the Mini-Mental State Examination in atrial fibrillation in the first 33 months of treatment other than that provided by preventing clinical stroke.
Clinical Trial Registration—
URL: http://www.controlled-trials.com. Unique identifier: ISRCTN89345269.
Source: Stroke - Category: Neurology Authors: Mavaddat, N., Roalfe, A., Fletcher, K., Lip, G. Y. H., Hobbs, F. D. R., Fitzmaurice, D., Mant, J. Tags: Arrhythmias, clinical electrophysiology, drugs, Primary and Secondary Stroke Prevention, Anticoagulants Clinical Sciences Source Type: research
More News: Arrhythmia | Aspirin | Atrial Fibrillation | Clinical Trials | Coumadin | Men | Neurology | Primary Care | Stroke | Study | Warfarin